The federal government is looking at rescheduling cannabis, meaning fewer restrictions for the plant and the industry.
The proposal received thousands of comments and now experts are weighing in.
According to the DEA, the drugs currently are classified on a scale of one to five.
President of Smart Approaches to Marijuana, Dr. Kevin Sabet, said rescheduling marijuana would provide tax breaks to large companies.
“We would never want to give Purdue Pharma and these Oxycontin companies a lot of tax breaks for breaking the law for doing something that’s harmful to the American people,” Sabet said.
Read the entire article HERE.